ENPP2 and primary biliary cholangitis: This finding supports the notion that ATX, unlike other laboratory parameters, is closely associated with disease-specific symptoms in PBC patients and that ATX inhibitors or LPA receptor antagonists may be of potential benefit in the treatment of pruritus and other symptoms related to chronic cholestasis.